Stereotaxis (NYSEAMERICAN:STXS – Get Free Report) is expected to release its Q1 2025 earnings data after the market closes on Monday, May 12th. Analysts expect Stereotaxis to post earnings of ($0.07) per share and revenue of $6.88 million for the quarter.
Stereotaxis Stock Down 1.4 %
Shares of STXS opened at $2.13 on Friday. Stereotaxis has a 52-week low of $1.54 and a 52-week high of $2.72. The company has a 50-day simple moving average of $1.88 and a 200-day simple moving average of $2.07. The company has a market capitalization of $180.47 million, a PE ratio of -7.61 and a beta of 1.54.
Insider Activity
In other news, Director Paul J. Isaac purchased 38,000 shares of the stock in a transaction dated Monday, March 10th. The stock was acquired at an average cost of $1.81 per share, for a total transaction of $68,780.00. Following the completion of the acquisition, the director now directly owns 87,299 shares in the company, valued at $158,011.19. This represents a 77.08 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 18.52% of the company’s stock.
Stereotaxis Company Profile
Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.
Featured Articles
- Five stocks we like better than Stereotaxis
- Best Stocks Under $10.00
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
- Investing in Travel Stocks Benefits
- Here’s The Reason Goldman Sachs Is Bullish On MercadoLibre Stock
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Analyst-Favorite Bitcoin Miner CleanSpark: Worth the Hype?
Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with MarketBeat.com's FREE daily email newsletter.